Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026)
Neuroone Medical Technologies posted quarterly Change in Receivables of -$235349.0 for Q1 2026, up 88.52% year-on-year from -$124840.1 in Q1 2025, and down 116.85% on a QoQ basis from $1.4 million in Q4 2025.
Neuroone Medical Technologies (NMTC) has 7 years of Change in Receivables data on file, last reported at -$235349.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 88.52% year-over-year to -$235349.0; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 989.87% YoY), and the FY2025 full-year result was $1.1 million, up 516.05% from the prior year.
- Change in Receivables for Q1 2026 stood at -$235349.0, down from $1.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.2 million in Q4 2024 and bottomed at -$2.1 million in Q1 2025.
- The 5-year median for Change in Receivables is $12098.0 (2022), against an average of $150118.1.
- The widest annual swing landed in 2023, when Change in Receivables soared 892.25%; it then slumped 16849.45% in 2025.
- A 5-year view of Change in Receivables shows it stood at $62082.0 in 2022, then soared by 775.29% to $543399.0 in 2023, then surged by 303.44% to $2.2 million in 2024, then tumbled by 36.27% to $1.4 million in 2025, then slumped by 116.85% to -$235349.0 in 2026.
- The last three Change in Receivables figures came in at -$235349.0 (Q1 2026), $1.4 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | -235,349.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -235,349.00 |
| Mar 31, 2026 | -235,349.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | -318,780.00 |
| Jun 30, 2025 | -318,780.00 |
| Mar 31, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | -233,915.00 |
| Sep 30, 2024 | -233,915.00 |
| Jun 30, 2024 | -145,088.00 |
| Jun 30, 2024 | -145,088.00 |
| Mar 31, 2024 | 12,240.00 |
| Mar 31, 2024 | 12,240.00 |
| Dec 31, 2023 | 543,399.00 |
| Dec 31, 2023 | 543,399.00 |
| Jun 30, 2023 | -213,952.00 |
| Jun 30, 2023 | -213,952.00 |
| Mar 31, 2023 | 118,633.00 |
| Mar 31, 2023 | 118,633.00 |
| Dec 31, 2022 | 62,082.00 |
| Dec 31, 2022 | 62,082.00 |
| Sep 30, 2022 | 33,237.00 |
| Sep 30, 2022 | 33,237.00 |
| Jun 30, 2022 | -36,584.00 |
| Jun 30, 2022 | -36,584.00 |
| Mar 31, 2022 | 11,956.00 |
| Mar 31, 2022 | 11,956.00 |
| Dec 31, 2021 | -23,708.00 |
| Dec 31, 2021 | -23,708.00 |
| Sep 30, 2021 | 8,240.00 |
| Sep 30, 2021 | 8,240.00 |
| Dec 31, 2020 | 71,474.00 |
| Dec 31, 2020 | 71,474.00 |